• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

路易体帕金森病伴杂合型帕金森蛋白剂量突变

Parkinson's disease with Lewy bodies associated with a heterozygous PARKIN dosage mutation.

作者信息

Sharp Madeleine E, Marder Karen S, Côté Lucien, Clark Lorraine N, Nichols William C, Vonsattel Jean-Paul, Alcalay Roy N

机构信息

Department of Neurology, Columbia University, New York, New York, USA.

出版信息

Mov Disord. 2014 Apr;29(4):566-8. doi: 10.1002/mds.25792. Epub 2013 Dec 27.

DOI:10.1002/mds.25792
PMID:24375549
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4281030/
Abstract

BACKGROUND

PARKIN-related disease remains incompletely understood. First, the pathogenicity of heterozygous PARKIN mutations is unclear, although some evidence supports causality. Second, unlike sporadic Parkinson's disease (PD), Lewy bodies are present only in a minority of cases. Only one other heterozygote PARKIN carrier with autopsy findings has been described. Our case adds to the broadening pathological and clinical phenotype of PARKIN-related disease.

METHODS

Clinical chart, genetic analysis, and pathological findings of a patient with familial PD are reviewed.

RESULTS

A 44-year-old man developed slowly progressive tremor-predominant PD with excellent response to levodopa. Genetic analysis revealed a heterozygous PARKIN exon 3-4 deletion, also present in 2 family members with early-onset PD. Postmortem examination showed severe neuronal loss in the substantia nigra and nucleus coeruleus with the presence of diffuse Lewy bodies.

CONCLUSIONS

The deletion is unlikely an incidental finding considering family history, age at onset, and the presence of clinical and pathological features not typical of sporadic PD.

摘要

背景

与帕金蛋白(PARKIN)相关的疾病仍未被完全理解。首先,尽管有一些证据支持因果关系,但杂合性PARKIN突变的致病性尚不清楚。其次,与散发性帕金森病(PD)不同,路易小体仅在少数病例中出现。仅有另外一例有尸检结果的杂合性PARKIN携带者被报道过。我们的病例增加了与PARKIN相关疾病不断扩大的病理和临床表型。

方法

回顾了一名家族性PD患者的临床病历、基因分析和病理结果。

结果

一名44岁男性患以震颤为主的缓慢进展性PD,对左旋多巴反应良好。基因分析显示存在杂合性PARKIN外显子3 - 4缺失,两名早发性PD家族成员也有此缺失。尸检显示黑质和蓝斑有严重神经元丢失,并存在弥漫性路易小体。

结论

考虑到家族史、发病年龄以及存在散发性PD不典型的临床和病理特征,该缺失不太可能是偶然发现。

相似文献

1
Parkinson's disease with Lewy bodies associated with a heterozygous PARKIN dosage mutation.路易体帕金森病伴杂合型帕金森蛋白剂量突变
Mov Disord. 2014 Apr;29(4):566-8. doi: 10.1002/mds.25792. Epub 2013 Dec 27.
2
Lewy body pathology in a patient with a homozygous parkin deletion.路易体病理改变见于一名纯合子 parkin 缺失患者。
Mov Disord. 2013 Mar;28(3):388-91. doi: 10.1002/mds.25346. Epub 2013 Feb 11.
3
Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers.一个有77名帕金基因突变携带者的大家族中的路易体帕金森病。
Ann Neurol. 2005 Sep;58(3):411-22. doi: 10.1002/ana.20587.
4
Lewy bodies and parkinsonism in families with parkin mutations.携带帕金基因突变的家族中的路易小体与帕金森症
Ann Neurol. 2001 Sep;50(3):293-300. doi: 10.1002/ana.1132.
5
Importance of familial Parkinson's disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson's disease.家族性帕金森病和帕金森综合征对理解散发性帕金森病黑质变性的重要性。
J Neural Transm Suppl. 2000(60):101-16. doi: 10.1007/978-3-7091-6301-6_6.
6
Neuropathological findings in PINK1-associated Parkinson's disease.与PINK1相关的帕金森病的神经病理学发现。
Parkinsonism Relat Disord. 2020 Sep;78:105-108. doi: 10.1016/j.parkreldis.2020.07.023. Epub 2020 Aug 9.
7
Lewy body pathology and typical Parkinson disease in a patient with a heterozygous (R275W) mutation in the Parkin gene (PARK2).一名携带帕金基因(PARK2)杂合(R275W)突变的患者出现路易体病理改变及典型帕金森病。
Acta Neuropathol. 2012 Jun;123(6):901-3. doi: 10.1007/s00401-012-0991-7. Epub 2012 May 4.
8
Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's disease.Parkin 和 PINK1 帕金森病可能代表不同于路易体帕金森病的黑质线粒体细胞病变。
Parkinsonism Relat Disord. 2009 Dec;15(10):721-7. doi: 10.1016/j.parkreldis.2009.09.010. Epub 2009 Oct 7.
9
An autopsy case of PARK2 due to a homozygous exon 2 deletion of parkin and associated with α-synucleinopathy.一例因parkin基因外显子2纯合缺失导致的PARK2尸检病例,并与α-突触核蛋白病相关。
Neuropathology. 2021 Aug;41(4):293-300. doi: 10.1111/neup.12735. Epub 2021 Jun 13.
10
Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.帕金蛋白定位于帕金森病和路易体痴呆的路易小体中。
Am J Pathol. 2002 May;160(5):1655-67. doi: 10.1016/S0002-9440(10)61113-3.

引用本文的文献

1
Formation of seeding-competent α-synuclein aggregates in parkin-deficient iPSC-derived human neurons.在缺乏parkin的诱导多能干细胞衍生的人类神经元中形成具有种子形成能力的α-突触核蛋白聚集体。
NPJ Parkinsons Dis. 2025 Jun 21;11(1):180. doi: 10.1038/s41531-025-01038-4.
2
Deficiency of parkin causes neurodegeneration and accumulation of pathological α-synuclein in monkey models.缺乏 parkin 会导致猴模型中的神经退行性变和病理性 α-突触核蛋白的积累。
J Clin Invest. 2024 Oct 15;134(20):e179633. doi: 10.1172/JCI179633.
3
Peripheral cutaneous synucleinopathy characteristics in genetic Parkinson's disease.

本文引用的文献

1
Cognitive and motor function in long-duration PARKIN-associated Parkinson disease.长程 PARKIN 相关帕金森病的认知和运动功能。
JAMA Neurol. 2014 Jan;71(1):62-7. doi: 10.1001/jamaneurol.2013.4498.
2
Parkin disease and the Lewy body conundrum.帕金森病与路易体难题。
Mov Disord. 2013 Jun;28(6):702-4. doi: 10.1002/mds.25486. Epub 2013 May 7.
3
Parkin disease: a clinicopathologic entity?帕金森病:一种临床病理实体?
遗传性帕金森病的外周皮肤α-突触核蛋白病特征
Front Neurol. 2024 May 1;15:1404492. doi: 10.3389/fneur.2024.1404492. eCollection 2024.
4
Interaction between Parkin and -Synuclein in -Mediated Parkinson's Disease.Parkin 与 -Synuclein 在 - 介导的帕金森病中的相互作用。
Cells. 2021 Jan 31;10(2):283. doi: 10.3390/cells10020283.
5
Amyloid-like oligomerization of AIMP2 contributes to α-synuclein interaction and Lewy-like inclusion.AIMP2的淀粉样寡聚化促进α-突触核蛋白相互作用和路易样包涵体形成。
Sci Transl Med. 2020 Nov 11;12(569). doi: 10.1126/scitranslmed.aax0091.
6
Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.锥体外系运动障碍的神经病理学和发病机制:批判性更新-I. 运动减少-僵硬的运动障碍。
J Neural Transm (Vienna). 2019 Aug;126(8):933-995. doi: 10.1007/s00702-019-02028-6. Epub 2019 Jun 18.
7
Are PARKIN patients ideal candidates for dopaminergic cell replacement therapies?帕金森病患者是多巴胺能细胞替代治疗的理想候选者吗?
Eur J Neurosci. 2019 Feb;49(4):453-462. doi: 10.1111/ejn.14314. Epub 2019 Jan 23.
8
Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature.遗传突触核蛋白病帕金森综合征的神经病理学:文献复习。
Mov Disord. 2017 Nov;32(11):1504-1523. doi: 10.1002/mds.27193.
9
Cardiac I-MIBG scintigraphy: A window into the brain in Parkinsonism?心肌碘代间位苄胍闪烁显像:帕金森病中了解大脑的一扇窗口?
J Nucl Cardiol. 2017 Feb;24(1):108-110. doi: 10.1007/s12350-015-0353-7. Epub 2015 Dec 7.
10
Myocardial I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations.纯合子和杂合子帕金森蛋白突变患者的心肌碘代苄胍闪烁扫描术
J Nucl Cardiol. 2017 Feb;24(1):103-107. doi: 10.1007/s12350-015-0332-z. Epub 2015 Dec 1.
JAMA Neurol. 2013 May;70(5):571-9. doi: 10.1001/jamaneurol.2013.172.
4
Lewy body pathology and typical Parkinson disease in a patient with a heterozygous (R275W) mutation in the Parkin gene (PARK2).一名携带帕金基因(PARK2)杂合(R275W)突变的患者出现路易体病理改变及典型帕金森病。
Acta Neuropathol. 2012 Jun;123(6):901-3. doi: 10.1007/s00401-012-0991-7. Epub 2012 May 4.
5
The neuropathology of genetic Parkinson's disease.遗传帕金森病的神经病理学。
Mov Disord. 2012 Jun;27(7):831-42. doi: 10.1002/mds.24962. Epub 2012 Mar 26.
6
Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study.帕金森病杂合子和复合杂合子患者的嗅觉:CORE-PD 研究。
Neurology. 2011 Jan 25;76(4):319-26. doi: 10.1212/WNL.0b013e31820882aa. Epub 2010 Dec 29.
7
Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study.帕金森病相关 Parkin 基因突变携带者的神经心理学特征:CORE-PD 研究。
J Int Neuropsychol Soc. 2011 Jan;17(1):91-100. doi: 10.1017/S1355617710001190. Epub 2010 Nov 24.
8
Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.早发性帕金森病中帕金基因突变的预测因素:早发性帕金森病风险联盟研究
Arch Neurol. 2010 Jun;67(6):731-8. doi: 10.1001/archneurol.2010.95.
9
The epidemiology of dementia associated with Parkinson disease.帕金森病相关痴呆的流行病学。
J Neurol Sci. 2010 Feb 15;289(1-2):18-22. doi: 10.1016/j.jns.2009.08.034. Epub 2009 Sep 4.
10
Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations.与简单序列突变相比,帕金森病相关蛋白(Parkin)剂量突变在家族性帕金森病中具有更强的致病性。
Neurology. 2009 Jul 28;73(4):279-86. doi: 10.1212/WNL.0b013e3181af7a33.